Title: Vaccine development: how scientific collaboration and communication help prevent the spread of disease: an interview with Erol Fikrig, MD.
Abstract: Erol Fikrig, MD, is a Waldemar Von Zedtwitz Professor of Medicine in Infectious Diseases, as well as a Professor of Epidemiology (Microbial Diseases) and Microbial Pathogenesis at the Yale School of Medicine. Dr. Fikrig received both his BA and MD from Cornell University. From there, he was an Internal Medicine resident at Vanderbilt University Hospital, and then completed a fellowship in Infectious Diseases at Yale University. Dr. Fikrig now is a senior research scientist at Yale, where he acts as a Howard Hughes Medical Institute investigator and Section Chief for Infectious Diseases.
Over the course of his career, Dr. Fikrig has had a broad impact on our understanding of Lyme disease and played a key role in the development of the first and only Lyme disease vaccine to be brought to market. Currently, his laboratory focuses on studying vector-borne diseases such as Lyme disease, human granulocytic ehrlichiosis, and West Nile virus.
In this interview, Dr. Fikrig discusses his background and interest in the molecular pathogenesis of infectious diseases. He shares with us a unique story about the development of the Lyme disease vaccine and the hurdles that arose during this process. Additionally, he comments on the current status of vaccination in the United States and what struggles remain in educating the public on the benefits of such preventive measures.
Publication Year: 2014
Publication Date: 2014-12-01
Language: en
Type: article
Indexed In: ['pubmed']
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot